+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oral Antiviral Market 2024 Edition: Market Size, Trends, Opportunities and Forecast by Drug Class, Indication, Distribution Channel, Region, By Country: 2020-2030

  • PDF Icon

    Report

  • 296 Pages
  • July 2024
  • Region: Global
  • Azoth Analytics
  • ID: 5989240
Description Jump to:
This report highlights different factors and opportunities prevailing in the “Global Oral Antiviral Market (2024 Edition)”. According to the report, the Global Oral Antiviral Market valued at USD 37.3 Billion in 2023 is expected to grow at a CAGR of 3.6% during 2025-2030.

The report explores a multi-faceted opportunity landscape in terms of market segmentation by Drug Class (Protease Inhibitors (PIs), Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Integrase Inhibitors and Other Drug Classes), By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza and Other Indications) and By Distribution Channel (Hospital & Retail Pharmacies and Online Pharmacies)

Market Overview

The Oral Antiviral market has witnessed significant growth in recent years, driven by the increasing prevalence of viral infections, advancements in antiviral drug development, and the rising demand for effective oral treatments. Oral antivirals are medications administered orally to treat viral infections such as influenza, hepatitis, HIV, and COVID-19. The market's expansion is primarily fueled by the need for convenient and effective antiviral therapies that improve patient compliance and outcomes.

One of the primary drivers of the Oral Antiviral market is the increasing prevalence of viral infections worldwide. The global burden of viral diseases such as influenza, hepatitis, and HIV has led to a greater demand for effective antiviral treatments. Additionally, the COVID-19 pandemic has highlighted the critical need for antiviral therapies, further driving market growth.

Technological advancements have significantly impacted the Oral Antiviral market, leading to the development of innovative and potent antiviral drugs. Advances in drug discovery, formulation technologies, and delivery systems have resulted in oral antivirals that offer improved efficacy, safety, and patient adherence. These advancements are crucial for addressing the evolving challenges of viral infections and improving treatment outcomes.

The growing focus on pandemic preparedness and the need for effective treatments for emerging viral diseases have also played a crucial role in the market's expansion. Governments and healthcare organizations are investing in antiviral research and development to enhance their readiness for future pandemics and improve public health outcomes.

Sustainability trends are influencing the Oral Antiviral market as well. Pharmaceutical companies are increasingly focusing on developing environmentally friendly production processes and sustainable packaging solutions. This shift is driven by regulatory pressures and a growing awareness of environmental sustainability within the healthcare industry.

Segment Insights

By application, the hepatitis segment holds the largest market share, accounting for approximately 40% of the global Oral Antiviral market in 2023. Hepatitis B and C infections are prevalent worldwide, driving the demand for effective oral antiviral treatments in this segment.

Geographical Insights

Americas represent the largest market for Oral Antivirals in value terms, driven by the high prevalence of viral infections, advanced healthcare infrastructure, and significant investments in antiviral research and development. The United States, in particular, is a key market due to its strong focus on healthcare innovation and extensive use of antiviral therapies.

In the Americas, the market is further bolstered by favorable reimbursement policies, increasing healthcare expenditure, and a strong focus on pandemic preparedness. The presence of well-established healthcare facilities and a high level of awareness about viral diseases contribute to the market's dominance in this region.

The Asia Pacific region is expected to witness the highest growth rate due to the increasing prevalence of viral infections, growing healthcare expenditure, and rising investments in antiviral drug development. Countries like China, India, and Japan are at the forefront of this growth, with expanding healthcare infrastructure and a growing focus on improving public health.

Market Segmentation

By Drug Class

  • Protease Inhibitors (PIs)
  • Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
  • Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
  • Integrase Inhibitors
  • Other Drug Classes

By Indication

  • Human Immunodeficiency Virus (HIV)
  • Hepatitis
  • Influenza
  • Other Indications

By Distribution Channel

  • Hospital & Retail Pharmacies
  • Online Pharmacies

By Geography

  • Americas (The United States, Canada, Brazil, Mexico, Rest of Americas)
  • Europe (United Kingdom, Germany, France, Italy, Spain, Turkey, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, South Korea, India, Singapore, Indonesia, Rest of Asia Pacific)
  • Middle East and Africa (GCC, Israel, South Africa, Rest of Middle East and Africa)

Key Companies

The report assesses the competitive developments, strategies, mergers and acquisitions and new product development and market share portfolio of top 15 companies. Key companies in the Global Oral Antiviral Market include:
  • AbbVie Inc.
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd.
  • Bristol-Myers Squibb Company
  • F. Hoffman-La Roche Ltd.
  • Merck & Co., Inc.
  • Viatris Inc.
  • Amneal Pharmaceuticals LLC
  • Gilead Sciences, Inc.
  • Other Leading Companies

Reasons to buy this report:

  • In-Depth Comparative Assessment of Top 20 Markets in the Oral Antiviral Industry: Comparative assessment of 20 leading countries highlighting the total addressable market, opportunities, lucrative segments and competitive positioning of leading companies.
  • Comprehensive Historical, Present, and Future Analytics of the Oral Antiviral Market: A deep dive in the historical (2020-2023), current (2024) and forecast (2025-2030) market analytics of Oral Antiviral Market.
  • Detailed Analysis of Oral Antiviral Market By Drug Class, Indication, and Distribution Channel Across 20 Countries
  • Beyond the Purchase: 90 Days of Support
  • Direct Access to Analysts: Have questions after reading the report? Our expert analysts are just a call or email away.
  • Customized Assistance: Whether you're integrating insights into your strategy or have questions about market dynamics, our team provides tailored support to meet your specific business needs.
  • Data Customization Requests: During the support period, you have the flexibility to request additional data cuts or deeper dives into specific areas of interest.
  • Gain insights specific to new entrants or new market areas to tap: The study provides detailed market entry strategies, including analysis of barriers to entry, pricing strategies, opportunities, trends, drivers, and challenges and product positioning using the Opportunity Portfolio Matrix (OPM)
  • Strategic Industry Movements: Tracking Competitive Developments and Key Players in the Market: The report covers competitive strategies, mergers & acquisitions, new developments, future plans and market share analysis of ~15 top companies

Table of Contents

1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Analyst Recommendations
3. Global Oral Antiviral Market: Historic and Forecast
3.1 Impact Analysis of Macro Economic Factors on Global Oral Antiviral Market
3.2 Oral Antiviral Type Matrix
3.3 Global Oral Antiviral Market: Dashboard
3.4 Global Oral Antiviral Market: Market Size and CAGR, By Value, 2020-2030 (USD Billion & CAGR)
3.5 Global Oral Antiviral Market: Market Value Assessment
3.6 Assessment Degree of Impact of COVID-19 on Global Oral Antiviral Market
3.7 Global Oral Antiviral Market Segmentation: By Drug Class
3.7.1 Global Oral Antiviral Market, By Drug Class Overview
3.7.2 Global Oral Antiviral Market Attractiveness Index, By Drug Class (2025-2030)
3.7.3 Global Oral Antiviral Market Size, By Protease Inhibitors (PIs), By Value, 2020H-2030F (USD Billion & CAGR)
3.7.4 Global Oral Antiviral Market Size, By Nucleoside Reverse Transcriptase Inhibitors (NRTIs), By Value, 2020H-2030F (USD Billion & CAGR)
3.7.5 Global Oral Antiviral Market Size, By Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), By Value, 2020H-2030F (USD Billion & CAGR)
3.7.6 Global Oral Antiviral Market Size, By Integrase Inhibitors, By Value, 2020H-2030F (USD Billion & CAGR)
3.7.7 Global Oral Antiviral Market Size, By Other Drug Classes, By Value, 2020H-2030F (USD Billion & CAGR)
3.8 Global Oral Antiviral Market Segmentation: By Indication
3.8.1 Global Oral Antiviral Market, By Indication Overview
3.8.2 Global Oral Antiviral Market Attractiveness Index, By Indication (2025-2030)
3.8.3 Global Oral Antiviral Market Size, By Human Immunodeficiency Virus (HIV), By Value, 2020H-2030F (USD Billion & CAGR)
3.8.4 Global Oral Antiviral Market Size, By Hepatitis, By Value, 2020H-2030F (USD Billion & CAGR)
3.8.5 Global Oral Antiviral Market Size, By Influenza, By Value, 2020H-2030F (USD Billion & CAGR)
3.8.6 Global Oral Antiviral Market Size, By Other Indications, By Value, 2020H-2030F (USD Billion & CAGR)
3.9 Global Oral Antiviral Market Segmentation: By Distribution Channel
3.9.1 Global Oral Antiviral Market, By Distribution Channel Overview
3.9.2 Global Oral Antiviral Market Attractiveness Index, By Distribution Channel (2025-2030)
3.9.3 Global Oral Antiviral Market Size, By Hospital & Retail Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
3.9.4 Global Oral Antiviral Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
4. Oral Antiviral Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas Oral Antiviral Market: Historic and Forecast
5.1 Americas Oral Antiviral Market: Snapshot
5.2 Americas Oral Antiviral Market: Market Size and CAGR, By Value, 2020-2030 (USD Billion & CAGR)
5.3 Americas Oral Antiviral Market: Key Factors
5.4 Americas Oral Antiviral Market: Segment Analysis
5.5 Americas Oral Antiviral Market Segmentation: By Drug Class
5.5.1 Americas Oral Antiviral Market, By Drug Class Overview
5.5.2 Americas Oral Antiviral Market Size, By Protease Inhibitors (PIs), By Value, 2020H-2030F (USD Billion & CAGR)
5.5.3 Americas Oral Antiviral Market Size, By Nucleoside Reverse Transcriptase Inhibitors (NRTIs), By Value, 2020H-2030F (USD Billion & CAGR)
5.5.4 Americas Oral Antiviral Market Size, By Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), By Value, 2020H-2030F (USD Billion & CAGR)
5.5.5 Americas Oral Antiviral Market Size, By Integrase Inhibitors, By Value, 2020H-2030F (USD Billion & CAGR)
5.5.6 Americas Oral Antiviral Market Size, By Other Drug Classes, By Value, 2020H-2030F (USD Billion & CAGR)
5.6 Americas Oral Antiviral Market Segmentation: By Indication
5.6.1 Americas Oral Antiviral Market, By Indication Overview
5.6.2 Americas Oral Antiviral Market Size, By Human Immunodeficiency Virus (HIV), By Value, 2020H-2030F (USD Billion & CAGR)
5.6.3 Americas Oral Antiviral Market Size, By Hepatitis, By Value, 2020H-2030F (USD Billion & CAGR)
5.6.4 Americas Oral Antiviral Market Size, By Influenza, By Value, 2020H-2030F (USD Billion & CAGR)
5.6.5 Americas Oral Antiviral Market Size, By Other Indications, By Value, 2020H-2030F (USD Billion & CAGR)
5.7 Americas Oral Antiviral Market Segmentation: By Distribution Channel
5.7.1 Americas Oral Antiviral Market, By Distribution Channel Overview
5.7.2 Americas Oral Antiviral Market Size, By Hospital & Retail Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
5.7.3 Americas Oral Antiviral Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
5.8 Americas Oral Antiviral Market Segmentation: By Country
5.8.1 Americas Oral Antiviral Market, by Country Overview
5.8.2 United States Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.8.2.1 United States Oral Antiviral Market, By Drug Class
5.8.2.2 United States Oral Antiviral Market, By Indication
5.8.2.3 United States Oral Antiviral Market, By Distribution Channel
5.8.3 Canada Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.8.3.1 Canada Oral Antiviral Market, By Drug Class
5.8.3.2 Canada Oral Antiviral Market, By Indication
5.8.3.3 Canada Oral Antiviral Market, By Distribution Channel
5.8.4 Brazil Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.8.4.1 Brazil Oral Antiviral Market, By Drug Class
5.8.4.2 Brazil Oral Antiviral Market, By Indication
5.8.4.3 Brazil Oral Antiviral Market, By Distribution Channel
5.8.5 Mexico Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.8.5.1 Mexico Oral Antiviral Market, By Drug Class
5.8.5.2 Mexico Oral Antiviral Market, By Indication
5.8.5.3 Mexico Oral Antiviral Market, By Distribution Channel
5.8.6 Rest of Americas Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.8.6.1 Rest of Americas Oral Antiviral Market, By Drug Class
5.8.6.2 Rest of Americas Oral Antiviral Market, By Indication
5.8.6.3 Rest of Americas Oral Antiviral Market, By Distribution Channel
6. Europe Oral Antiviral Market: Historic and Forecast
6.1 Europe Oral Antiviral Market: Snapshot
6.2 Europe Oral Antiviral Market: Market Size and CAGR, BY Value, 2020-2030 (USD Billion & CAGR)
6.3 Europe Oral Antiviral Market: Key Factors
6.4 Europe Oral Antiviral Market: Segment Analysis
6.5 Europe Oral Antiviral Market Segmentation: By Drug Class
6.5.1 Europe Oral Antiviral Market, By Drug Class Overview
6.5.2 Europe Oral Antiviral Market Size, By Protease Inhibitors (PIs), By Value, 2020H-2030F (USD Billion & CAGR)
6.5.3 Europe Oral Antiviral Market Size, By Nucleoside Reverse Transcriptase Inhibitors (NRTIs), By Value, 2020H-2030F (USD Billion & CAGR)
6.5.4 Europe Oral Antiviral Market Size, By Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), By Value, 2020H-2030F (USD Billion & CAGR)
6.5.5 Europe Oral Antiviral Market Size, By Integrase Inhibitors, By Value, 2020H-2030F (USD Billion & CAGR)
6.5.6 Europe Oral Antiviral Market Size, By Other Drug Classes, By Value, 2020H-2030F (USD Billion & CAGR)
6.6 Europe Oral Antiviral Market Segmentation: By Indication
6.6.1 Europe Oral Antiviral Market, By Indication Overview
6.6.2 Europe Oral Antiviral Market Size, By Human Immunodeficiency Virus (HIV), By Value, 2020H-2030F (USD Billion & CAGR)
6.6.3 Europe Oral Antiviral Market Size, By Hepatitis, By Value, 2020H-2030F (USD Billion & CAGR)
6.6.4 Europe Oral Antiviral Market Size, By Influenza, By Value, 2020H-2030F (USD Billion & CAGR)
6.6.5 Europe Oral Antiviral Market Size, By Other Indications, By Value, 2020H-2030F (USD Billion & CAGR)
6.7 Europe Oral Antiviral Market Segmentation: By Distribution Channel
6.7.1 Europe Oral Antiviral Market, By Distribution Channel Overview
6.7.2 Europe Oral Antiviral Market Size, By Hospital & Retail Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
6.7.3 Europe Oral Antiviral Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
6.8 Europe Oral Antiviral Market Segmentation: By Country
6.8.1 Europe Oral Antiviral Market, by Country Overview
6.8.2 Russia Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.2.1 Russia Oral Antiviral Market, By Drug Class
6.8.2.2 Russia Oral Antiviral Market, By Indication
6.8.2.3 Russia Oral Antiviral Market, By Distribution Channel
6.8.3 France Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.3.1 France Oral Antiviral Market, By Drug Class
6.8.3.2 France Oral Antiviral Market, By Indication
6.8.3.3 France Oral Antiviral Market, By Distribution Channel
6.8.4 United Kingdom Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.4.1 United Kingdom Oral Antiviral Market, By Drug Class
6.8.4.2 United Kingdom Oral Antiviral Market, By Indication
6.8.4.3 United Kingdom Oral Antiviral Market, By Distribution Channel
6.8.5 Germany Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.5.1 Germany Oral Antiviral Market, By Drug Class
6.8.5.2 Germany Oral Antiviral Market, By Indication
6.8.5.3 Germany Oral Antiviral Market, By Distribution Channel
6.8.6 Italy Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.6.1 Italy Oral Antiviral Market, By Drug Class
6.8.6.2 Italy Oral Antiviral Market, By Indication
6.8.6.3 Italy Oral Antiviral Market, By Distribution Channel
6.8.7 Spain Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.7.1 Spain Oral Antiviral Market, By Drug Class
6.8.7.2 Spain Oral Antiviral Market, By Indication
6.8.7.3 Spain Oral Antiviral Market, By Distribution Channel
6.8.8 Turkey Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.8.1 Turkey Oral Antiviral Market, By Drug Class
6.8.8.2 Turkey Oral Antiviral Market, By Indication
6.8.8.3 Turkey Oral Antiviral Market, By Distribution Channel
6.8.9 Rest of Europe Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.9.1 Rest of Europe Oral Antiviral Market, By Drug Class
6.8.9.2 Rest of Europe Oral Antiviral Market, By Indication
6.8.9.3 Rest of Europe Oral Antiviral Market, By Distribution Channel
7. Asia Pacific Oral Antiviral Market: Historic and Forecast
7.1 Asia Pacific Oral Antiviral Market: Snapshot
7.2 Asia Pacific Oral Antiviral Market: Market Size and CAGR, By Value, 2020-2030 (USD Billion & CAGR)
7.3 Asia Pacific Oral Antiviral Market: Key Factors
7.4 Asia Pacific Oral Antiviral Market: Segment Analysis
7.5 Asia Pacific Oral Antiviral Market Segmentation: By Drug Class
7.5.1 Asia Pacific Oral Antiviral Market, By Drug Class Overview
7.5.2 Asia Pacific Oral Antiviral Market Size, By Protease Inhibitors (PIs), By Value, 2020H-2030F (USD Billion & CAGR)
7.5.3 Asia Pacific Oral Antiviral Market Size, By Nucleoside Reverse Transcriptase Inhibitors (NRTIs), By Value, 2020H-2030F (USD Billion & CAGR)
7.5.4 Asia Pacific Oral Antiviral Market Size, By Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), By Value, 2020H-2030F (USD Billion & CAGR)
7.5.5 Asia Pacific Oral Antiviral Market Size, By Integrase Inhibitors, By Value, 2020H-2030F (USD Billion & CAGR)
7.5.6 Asia Pacific Oral Antiviral Market Size, By Other Drug Classes, By Value, 2020H-2030F (USD Billion & CAGR)
7.6 Asia Pacific Oral Antiviral Market Segmentation: By Indication
7.6.1 Asia Pacific Oral Antiviral Market, By Indication Overview
7.6.2 Asia Pacific Oral Antiviral Market Size, By Human Immunodeficiency Virus (HIV), By Value, 2020H-2030F (USD Billion & CAGR)
7.6.3 Asia Pacific Oral Antiviral Market Size, By Hepatitis, By Value, 2020H-2030F (USD Billion & CAGR)
7.6.4 Asia Pacific Oral Antiviral Market Size, By Influenza, By Value, 2020H-2030F (USD Billion & CAGR)
7.6.5 Asia Pacific Oral Antiviral Market Size, By Other Indications, By Value, 2020H-2030F (USD Billion & CAGR)
7.7 Asia Pacific Oral Antiviral Market Segmentation: By Distribution Channel
7.7.1 Asia Pacific Oral Antiviral Market, By Distribution Channel Overview
7.7.2 Asia Pacific Oral Antiviral Market Size, By Hospital & Retail Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
7.7.3 Asia Pacific Oral Antiviral Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
7.8 Asia Pacific Oral Antiviral Market Segmentation: By Country
7.8.1 Asia Pacific Oral Antiviral Market, by Country Overview
7.8.2 China Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.2.1 China Oral Antiviral Market, By Drug Class
7.8.2.2 China Oral Antiviral Market, By Indication
7.8.2.3 China Oral Antiviral Market, By Distribution Channel
7.8.3 India Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.3.1 India Oral Antiviral Market, By Drug Class
7.8.3.2 India Oral Antiviral Market, By Indication
7.8.3.3 India Oral Antiviral Market, By Distribution Channel
7.8.4 South Korea Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.4.1 South Korea Oral Antiviral Market, By Drug Class
7.8.4.2 South Korea Oral Antiviral Market, By Indication
7.8.4.3 South Korea Oral Antiviral Market, By Distribution Channel
7.8.5 Japan Korea Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.5.1 Japan Oral Antiviral Market, By Drug Class
7.8.5.2 Japan Oral Antiviral Market, By Indication
7.8.5.3 Japan Oral Antiviral Market, By Distribution Channel
7.8.6 Singapore Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.6.1 Singapore Oral Antiviral Market, By Drug Class
7.8.6.2 Singapore Oral Antiviral Market, By Indication
7.8.6.3 Singapore Oral Antiviral Market, By Distribution Channel
7.8.7 Indonesia Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.7.1 Indonesia Oral Antiviral Market, By Drug Class
7.8.7.2 Indonesia Oral Antiviral Market, By Indication
7.8.7.3 Indonesia Oral Antiviral Market, By Distribution Channel
7.8.8 Rest of Asia Pacific Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.8.1 Rest of Asia Pacific Oral Antiviral Market, By Drug Class
7.8.8.2 Rest of Asia Pacific Oral Antiviral Market, By Indication
7.8.8.3 Rest of Asia Pacific Oral Antiviral Market, By Distribution Channel
8. Middle East & Africa Oral Antiviral Market: Historic and Forecast
8.1 Middle East & Africa Oral Antiviral Market: Snapshot
8.2 Middle East & Africa Oral Antiviral Market: Market Size and CAGR, By Value, 2020-2030 (USD Billion & CAGR)
8.3 Middle East & Africa Oral Antiviral Market: Key Factors
8.4 Middle East and Africa Oral Antiviral Market: Segment Analysis
8.5 Middle East & Africa Oral Antiviral Market Segmentation: By Drug Class
8.5.1 Middle East & Africa Oral Antiviral Market, By Drug Class Overview
8.5.2 Middle East & Africa Oral Antiviral Market Size, By Protease Inhibitors (PIs), By Value, 2020H-2030F (USD Billion & CAGR)
8.5.3 Middle East & Africa Oral Antiviral Market Size, By Nucleoside Reverse Transcriptase Inhibitors (NRTIs), By Value, 2020H-2030F (USD Billion & CAGR)
8.5.4 Middle East & Africa Oral Antiviral Market Size, By Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), By Value, 2020H-2030F (USD Billion & CAGR)
8.5.5 Middle East & Africa Oral Antiviral Market Size, By Integrase Inhibitors, By Value, 2020H-2030F (USD Billion & CAGR)
8.5.6 Middle East & Africa Oral Antiviral Market Size, By Other Drug Classes, By Value, 2020H-2030F (USD Billion & CAGR)
8.6 Middle East & Africa Oral Antiviral Market Segmentation: By Indication
8.6.1 Middle East & Africa Oral Antiviral Market, By Indication Overview
8.6.2 Middle East & Africa Oral Antiviral Market Size, By Human Immunodeficiency Virus (HIV), By Value, 2020H-2030F (USD Billion & CAGR)
8.6.3 Middle East & Africa Oral Antiviral Market Size, By Hepatitis, By Value, 2020H-2030F (USD Billion & CAGR)
8.6.4 Middle East & Africa Oral Antiviral Market Size, By Influenza, By Value, 2020H-2030F (USD Billion & CAGR)
8.6.5 Middle East & Africa Oral Antiviral Market Size, By Other Indications, By Value, 2020H-2030F (USD Billion & CAGR)
8.7 Middle East & Africa Oral Antiviral Market Segmentation: By Distribution Channel
8.7.1 Middle East & Africa Oral Antiviral Market, By Distribution Channel Overview
8.7.2 Middle East & Africa Oral Antiviral Market Size, By Hospital & Retail Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
8.7.3 Middle East & Africa Oral Antiviral Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
8.8 Middle East & Africa Oral Antiviral Market Segmentation: By Country
8.8.1 Middle East & Africa Oral Antiviral Market, by Country Overview
8.8.2 GCC Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
8.8.2.1 GCC Oral Antiviral Market, By Drug Class
8.8.2.2 GCC Oral Antiviral Market, By Indication
8.8.2.3 GCC Oral Antiviral Market, By Distribution Channel
8.8.3 Israel Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
8.8.3.1 Israel Oral Antiviral Market, By Drug Class
8.8.3.2 Israel Oral Antiviral Market, By Indication
8.8.3.3 Israel Oral Antiviral Market, By Distribution Channel
8.8.4 South Africa Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
8.8.4.1 South Africa Oral Antiviral Market, By Drug Class
8.8.4.2 South Africa Oral Antiviral Market, By Indication
8.8.4.3 South Africa Oral Antiviral Market, By Distribution Channel
8.8.5 Rest of Middle East and Africa Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
8.8.5.1 Rest of Middle East and Africa Oral Antiviral Market, By Drug Class
8.8.5.2 Rest of Middle East and Africa Oral Antiviral Market, By Indication
8.8.5.3 Rest of Middle East and Africa Oral Antiviral Market, By Distribution Channel
9. Market Dynamics
9.1 Impact assessment of Market Dynamics on Oral Antiviral Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Industry Ecosystem Analysis
10.1 Porter Analysis
11. Competitive Positioning
11.1 Companies Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Oral Antiviral Market
11.4 Company Profiles
11.4.1 AbbVie Inc.
11.4.2 Johnson & Johnson
11.4.3 GlaxoSmithKline plc
11.4.4 Teva Pharmaceutical Industries Ltd.
11.4.5 Bristol-Myers Squibb Company
11.4.6 F. Hoffman-La Roche Ltd.
11.4.7 Merck & Co., Inc.
11.4.8 Viatris Inc.
11.4.9 Amneal Pharmaceuticals LLC
11.4.10 Gilead Sciences, Inc.
12. About the Publisher & Disclaimer
List of Figures
Figure 1: Oral Antiviral, Comparison of Leading Countries, 2023 (%)
Figure 2: Oral Antiviral, Comparison of Leading Countries, 2030 (%)
Figure 3: Oral Antiviral Type Matrix
Figure 4: Oral Antiviral Demand Analysis
Figure 5: Global Oral Antiviral Market Size, By Value, 2020-2023 (USD Billion)
Figure 6: Global Oral Antiviral Market Size, By Value, 2024-2030 (USD Billion)
Figure 7: Global Oral Antiviral Market Share, By Indication, 2023 (%)
Figure 8: Global Oral Antiviral Market CAGR, 2020-2023 (%)
Figure 9: Global Oral Antiviral Market CAGR, 2025-2030 (%)
Figure 10: Global Oral Antiviral Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 11: Market Attractiveness Analysis of Global Oral Antiviral Market, By Drug Class (2025-2030)
Figure 12: Global Oral Antiviral Market Size, By Protease Inhibitors (PIs), By Value, 2020H-2030F (USD Billion & CAGR)
Figure 13: Global Oral Antiviral Market Absolute Opportunity, By Protease Inhibitors (PIs), 2020-2030 (USD Billion)
Figure 14: Global Oral Antiviral Market Size, By Nucleoside Reverse Transcriptase Inhibitors (NRTIs), By Value, 2020H-2030F (USD Billion & CAGR)
Figure 15: Global Oral Antiviral Market Absolute Opportunity, By Nucleoside Reverse Transcriptase Inhibitors (NRTIs), 2020-2030 (USD Billion)
Figure 16: Global Oral Antiviral Market Size, By Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), By Value, 2020H-2030F (USD Billion & CAGR)
Figure 17: Global Oral Antiviral Market Absolute Opportunity, By Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), 2020-2030 (USD Billion)
Figure 18: Global Oral Antiviral Market Size, By Integrase Inhibitors, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 19: Global Oral Antiviral Market Absolute Opportunity, By Integrase Inhibitors, 2020-2030 (USD Billion)
Figure 20: Global Oral Antiviral Market Size, By Other Drug Classes, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 21: Global Oral Antiviral Market Absolute Opportunity, By Other Drug Classes, 2020-2030 (USD Billion)
Figure 22: Market Attractiveness Analysis of Global Oral Antiviral Market, By Indication (2025-2030)
Figure 23: Global Oral Antiviral Market Size, By Human Immunodeficiency Virus (HIV), By Value, 2020H-2030F (USD Billion & CAGR)
Figure 24: Global Oral Antiviral Market Absolute Opportunity, By Human Immunodeficiency Virus (HIV), 2020-2030 (USD Billion)
Figure 25: Global Oral Antiviral Market Size, By Hepatitis, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 26: Global Oral Antiviral Market Absolute Opportunity, By Hepatitis, 2020-2030 (USD Billion)
Figure 27: Global Oral Antiviral Market Size, By Influenza, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 28: Global Oral Antiviral Market Absolute Opportunity, By Influenza, 2020-2030 (USD Billion)
Figure 29: Global Oral Antiviral Market Size, By Other Indications, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 30: Global Oral Antiviral Market Absolute Opportunity, By Other Indications, 2020-2030 (USD Billion)
Figure 31: Market Attractiveness Analysis of Global Oral Antiviral Market, By Distribution Channel (2025-2030)
Figure 32: Global Oral Antiviral Market Size, By Hospital & Retail Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 33: Global Oral Antiviral Market Absolute Opportunity, By Hospital & Retail Pharmacies, 2020-2030 (USD Billion)
Figure 34: Global Oral Antiviral Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 35: Global Oral Antiviral Market Absolute Opportunity, By Online Pharmacies, 2020-2030 (USD Billion)
Figure 36: Americas Oral Antiviral Market Size, By Value, 2020H-2030F (USD Billion)
Figure 37: Americas Oral Antiviral Market Share, By Indication, 2023 (%)
Figure 38: Americas Oral Antiviral Market Share, By Product Launches, 2023 (%)
Figure 39: Americas Oral Antiviral Market Share, By Leading Companies, 2023 (%)
Figure 40: Americas Oral Antiviral Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 41: Americas Oral Antiviral Market, By Protease Inhibitors (PIs), By Value, 2020H-2030F (USD Billions & CAGR)
Figure 42: Americas Oral Antiviral Market, By Nucleoside Reverse Transcriptase Inhibitors (NRTIs), By Value, 2020H-2030F (USD Billions & CAGR)
Figure 43: Americas Oral Antiviral Market, By Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), By Value, 2020H-2030F (USD Billions & CAGR)
Figure 44: Americas Oral Antiviral Market, By Integrase Inhibitors, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 45: Americas Oral Antiviral Market, By Other Drug Classes, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 46: Figure 46: Americas Oral Antiviral Market, By Human Immunodeficiency Virus (HIV), By Value, 2020H-2030F (USD Billions & CAGR)
Figure 47: Americas Oral Antiviral Market, By Hepatitis, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 48: Americas Oral Antiviral Market, By Influenza, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 49: Americas Oral Antiviral Market, By Other Indications, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 50: Americas Oral Antiviral Market, By Hospital & Retail Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 51: Americas Oral Antiviral Market, By Online Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 52: United States Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 53: United States Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 54: United States Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 55: United States Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 56: United States Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 57: Canada Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 58: Canada Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 59: Canada Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 60: Canada Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 61: Canada Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 62: Brazil Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 63: Brazil Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 64: Brazil Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 65: Brazil Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 66: Brazil Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 67: Mexico Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 68: Mexico Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 69: Mexico Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 70: Mexico Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 71: Mexico Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 72: Rest of Americas Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 73: Rest of Americas Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 74: Rest of Americas Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 75: Rest of Americas Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 76: Rest of Americas Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 77: Europe Oral Antiviral Market Size, By Value, 2020H-2030F (USD Billion)
Figure 78: Europe Oral Antiviral Market Share, By Indication, 2023 (%)
Figure 79: Europe Oral Antiviral Market Share, By Product Launches, 2023 (%)
Figure 80: Europe Oral Antiviral Market Share, By Leading Companies, 2023 (%)
Figure 81: Europe Oral Antiviral Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 82: Europe Oral Antiviral Market, By Protease Inhibitors (PIs), By Value, 2020H-2030F (USD Billions & CAGR)
Figure 83: Europe Oral Antiviral Market, By Nucleoside Reverse Transcriptase Inhibitors (NRTIs), By Value, 2020H-2030F (USD Billions & CAGR)
Figure 84: Europe Oral Antiviral Market, By Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), By Value, 2020H-2030F (USD Billions & CAGR)
Figure 85: Europe Oral Antiviral Market, By Integrase Inhibitors, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 86: Europe Oral Antiviral Market, By Other Drug Classes, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 87: Europe Oral Antiviral Market, By Human Immunodeficiency Virus (HIV), By Value, 2020H-2030F (USD Billions & CAGR)
Figure 88: Europe Oral Antiviral Market, By Hepatitis, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 89: Europe Oral Antiviral Market, By Influenza, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 90: Europe Oral Antiviral Market, By Other Indications, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 91: Europe Oral Antiviral Market, By Hospital & Retail Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 92: Europe Oral Antiviral Market, By Online Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 93: Russia Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 94: Russia Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 95: Russia Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 96: Russia Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 97: Russia Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 98: France Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 99: France Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 100: France Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 101: France Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 102: France Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 103: United Kingdom Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 104: United Kingdom Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 105: United Kingdom Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 106: United Kingdom Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 107: United Kingdom Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 108: Germany Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 109: Germany Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 110: Germany Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 111: Germany Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 112: Germany Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 113: Italy Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 114: Italy Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 115: Italy Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 116: Italy Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 117: Italy Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 118: Spain Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 119: Spain Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 120: Spain Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 121: Spain Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 122: Spain Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 123: Turkey Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 124: Turkey Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 125: Turkey Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 126: Turkey Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 127: Turkey Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 128: Rest of Europe Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 129: Rest of Europe Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 130: Rest of Europe Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 131: Rest of Europe Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 132: Rest of Europe Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 133: Asia Pacific Oral Antiviral Market Size, By Value, 2020H-2030F (USD Billion)
Figure 134: Asia Pacific Oral Antiviral Market Share, By Indication, 2023 (%)
Figure 135: Asia Pacific Oral Antiviral Market Share, By Product Launches, 2023 (%)
Figure 136: Asia Pacific Oral Antiviral Market Share, By Leading Companies, 2023 (%)
Figure 137: Asia Pacific Oral Antiviral Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 138: Asia Pacific Oral Antiviral Market, By Protease Inhibitors (PIs), By Value, 2020H-2030F (USD Billions & CAGR)
Figure 139: Asia Pacific Oral Antiviral Market, By Nucleoside Reverse Transcriptase Inhibitors (NRTIs), By Value, 2020H-2030F (USD Billions & CAGR)
Figure 140: Asia Pacific Oral Antiviral Market, By Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), By Value, 2020H-2030F (USD Billions & CAGR)
Figure 141: Asia Pacific Oral Antiviral Market, By Integrase Inhibitors, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 142: Asia Pacific Oral Antiviral Market, By Other Drug Classes, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 143: Asia Pacific Oral Antiviral Market, By Human Immunodeficiency Virus (HIV), By Value, 2020H-2030F (USD Billions & CAGR)
Figure 144: Asia Pacific Oral Antiviral Market, By Hepatitis, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 145: Asia Pacific Oral Antiviral Market, By Influenza, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 146: Asia Pacific Oral Antiviral Market, By Other Indications, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 147: Asia Pacific Oral Antiviral Market, By Hospital & Retail Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 148: Asia Pacific Oral Antiviral Market, By Online Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 149: China Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 150: China Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 151: China Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 152: China Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 153: China Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 154: India Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 155: India Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 156: India Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 157: India Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 158: India Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 159: South Korea Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 160: South Korea Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 161: South Korea Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 162: South Korea Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 163: South Korea Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 164: Japan Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 165: Japan Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 166: Japan Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 167: Japan Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 168: Japan Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 169: Singapore Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 170: Singapore Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 171: Singapore Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 172: Singapore Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 173: Singapore Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 174: Indonesia Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 175: Indonesia Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 176: Indonesia Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 177: Indonesia Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 178: Indonesia Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 179: Rest of Asia Pacific Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 180: Rest of Asia Pacific Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 181: Rest of Asia Pacific Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 182: Rest of Asia Pacific Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 183: Rest of Asia Pacific Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 184: Middle East and Africa Oral Antiviral Market Size, By Value, 2020H-2030F (USD Billion)
Figure 185: Middle East and Africa Oral Antiviral Market Share, By Indication, 2023 (%)
Figure 186: Middle East and Africa Oral Antiviral Market Share, By Product Launches, 2023 (%)
Figure 187: Middle East and Africa Oral Antiviral Market Share, By Leading Companies, 2023 (%)
Figure 188: Middle East and Africa Oral Antiviral Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 189: Middle East and Africa Oral Antiviral Market, By Protease Inhibitors (PIs), By Value, 2020H-2030F (USD Billions & CAGR)
Figure 190: Middle East and Africa Oral Antiviral Market, By Nucleoside Reverse Transcriptase Inhibitors (NRTIs), By Value, 2020H-2030F (USD Billions & CAGR)
Figure 191: Middle East and Africa Oral Antiviral Market, By Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), By Value, 2020H-2030F (USD Billions & CAGR)
Figure 192: Middle East and Africa Oral Antiviral Market, By Integrase Inhibitors, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 193: Middle East and Africa Oral Antiviral Market, By Other Drug Classes, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 194: Middle East and Africa Oral Antiviral Market, By Human Immunodeficiency Virus (HIV), By Value, 2020H-2030F (USD Billions & CAGR)
Figure 195: Middle East and Africa Oral Antiviral Market, By Hepatitis, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 196: Middle East and Africa Oral Antiviral Market, By Influenza, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 197: Middle East and Africa Oral Antiviral Market, By Other Indications, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 198: Middle East and Africa Oral Antiviral Market, By Hospital & Retail Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 199: Middle East and Africa Oral Antiviral Market, By Online Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 200: GCC Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 201: GCC Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 202: GCC Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 203: GCC Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 204: GCC Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 205: Israel Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 206: Israel Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 207: Israel Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 208: Israel Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 209: Israel Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 210: South Africa Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 211: South Africa Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 212: South Africa Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 213: South Africa Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 214: South Africa Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 215: Rest of Middle East and Africa Oral Antiviral Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 216: Rest of Middle East and Africa Oral Antiviral Market Value, By Distribution Channel, 2023 (USD Billion)
Figure 217: Rest of Middle East and Africa Oral Antiviral Market Share, By Drug Class, By Value, 2023 (%)
Figure 218: Rest of Middle East and Africa Oral Antiviral Market Share, By Indication, By Value, 2023 (%)
Figure 219: Rest of Middle East and Africa Oral Antiviral Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 220: Market Share of Prominent Companies of Global Oral Antiviral Market, 2023 (%)
List of Tables
Table A1: Global Impact of Macro Economic Factors, By Region
Table A2: United States Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A3: United States Oral Antiviral Market, By Drug Class, By Value, 2024-2030 (USD Billion)
Table A4: United States Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A5: United States Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A6: United States Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A7: United States Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A8: Canada Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A9: Canada Oral Antiviral Market, By Drug Class, By Value, 2024- 2030 (USD Billion)
Table A10: Canada Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A11: Canada Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A12: Canada Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A13: Canada Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A14: Brazil Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A15: Brazil Oral Antiviral Market, By Drug Class, By Value, 2024-2030 (USD Billion)
Table A16: Brazil Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A17: Brazil Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A18: Brazil Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A19: Brazil Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A20: Mexico Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A21: Mexico Oral Antiviral Market, By Drug Class, By Value, 2024-2030 (USD Billion)
Table A22: Mexico Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A23: Mexico Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A24: Mexico Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A25: Mexico Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A26: Rest of Americas Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A27: Rest of Americas Oral Antiviral Market, By Drug Class, By Value, 2024-2030 (USD Billion)
Table A28: Rest of Americas Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A29: Rest of Americas Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A30: Rest of Americas Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A31: Rest of Americas Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A32: Russia Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A33: Russia Oral Antiviral Market, By Drug Class, By Value, 2024-2030 (USD Billion)
Table A34: Russia Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A35: Russia Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A36: Russia Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A37: Russia Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A38: France Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A39: France Oral Antiviral Market, By Drug Class, By Value, 2024-2030 (USD Billion)
Table A40: France Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A41: France Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A42: France Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A43: France Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A44: United Kingdom Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A45: United Kingdom Oral Antiviral Market, By Drug Class, By Value, 2024-2030 (USD Billion)
Table A46: United Kingdom Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A47: United Kingdom Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A48: United Kingdom Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A49: United Kingdom Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A50: Germany Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A51: Germany Oral Antiviral Market, By Drug Class, By Value, 2024-2030 (USD Billion)
Table A52: Germany Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A53: Germany Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A54: Germany Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A55: Germany Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A56: Italy Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A57: Italy Oral Antiviral Market, By Drug Class, By Value, 2024-2030 (USD Billion)
Table A58: Italy Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A59: Italy Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A60: Italy Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A61: Italy Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A62: Spain Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A63: Spain Oral Antiviral Market, By Drug Class, By Value, 2024-2030 (USD Billion)
Table A64: Spain Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A65: Spain Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A66: Spain Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A67: Spain Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A68: Turkey Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A69: Turkey Oral Antiviral Market, By Drug Class, By Value, 2024-2030 (USD Billion)
Table A70: Turkey Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A71: Turkey Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A72: Turkey Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A73: Turkey Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A74: Rest of Europe Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A75: Rest of Europe Oral Antiviral Market, By Drug Class, By Value, 2024-2030 (USD Billion)
Table A76: Rest of Europe Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A77: Rest of Europe Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A78: Rest of Europe Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A79: Rest of Europe Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A80: China Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A81: China Oral Antiviral Market, By Drug Class, By Value, 2024-2030 (USD Billion)
Table A82: China Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A83: China Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A84: China Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A85: China Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A86: India Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A87: India Oral Antiviral Market, By Drug Class, By Value, 2024-2030 (USD Billion)
Table A88: India Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A89: India Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A90: India Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A91: India Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A92: South Korea Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A93: South Korea Oral Antiviral Market, By Drug Class, By Value, 2024-2030 (USD Billion)
Table A94: South Korea Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A95: South Korea Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A96: South Korea Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A97: South Korea Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A98: Japan Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A99: Japan Oral Antiviral Market, By Drug Class, By Value, 2024-2030 (USD Billion)
Table A100: Japan Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A101: Japan Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A102: Japan Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A103: Japan Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A104: Singapore Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A105: Singapore Oral Antiviral Market, By Drug Class, By Value, 2024-2030 (USD Billion)
Table A106: Singapore Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A107: Singapore Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A108: Singapore Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A109: Singapore Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A110: Indonesia Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A111: Indonesia Oral Antiviral Market, By Drug Class, By Value, 2024-2030 (USD Billion)
Table A112: Indonesia Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A113: Indonesia Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A114: Indonesia Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A115: Indonesia Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A116: Rest of Asia Pacific Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A117: Rest of Asia Pacific Oral Antiviral Market, By Drug Class, By Value, 2024-2030 (USD Billion)
Table A118: Rest of Asia Pacific Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A119: Rest of Asia Pacific Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A120: Rest of Asia Pacific Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A121: Rest of Asia Pacific Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A122: GCC Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A123: GCC Oral Antiviral Market, By Drug Class, By Value, 2024-2030 (USD Billion)
Table A124: GCC Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A125: GCC Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A126: GCC Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A127: GCC Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A128: Israel Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A129: Israel Oral Antiviral Market, By Drug Class, By Value, 2024-2030 (USD Billion)
Table A130: Israel Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A131: Israel Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A132: Israel Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A133: Israel Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A134: South Africa Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A135: South Africa Oral Antiviral Market, By Drug Class, By Value, 2024-2030 (USD Billion)
Table A136: South Africa Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A137: South Africa Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A138: South Africa Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A139: South Africa Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A140: Rest of Middle East and Africa Oral Antiviral Market, By Drug Class, By Value, 2020-2023 (USD Billion)
Table A141: Rest of Middle East and Africa Oral Antiviral Market, By Drug Class, By Value, 2024-2030 (USD Billion)
Table A142: Rest of Middle East and Africa Oral Antiviral Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A143: Rest of Middle East and Africa Oral Antiviral Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A144: Rest of Middle East and Africa Oral Antiviral Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A145: Rest of Middle East and Africa Oral Antiviral Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)

Related Topics

Related Reports

Antiviral Combination Therapy Global Market Report 2024 - Product Image

Antiviral Combination Therapy Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Antiviral Combination Therapy Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F - Product Image

Antiviral Combination Therapy Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

  • Report
  • 184 Pages
  • Global
From
Antiviral Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Antiviral Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • 150 Pages
  • Global
From
Direct-acting Antiviral Drug Market by Type, Indication, Route, Distribution Channel - Global Forecast 2025-2030 - Product Image

Direct-acting Antiviral Drug Market by Type, Indication, Route, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Antivirals Global Market Report 2024 - Product Image

Antivirals Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From

About the Oral Antiviral Market

The Oral Antiviral market is a subset of the Infectious Diseases Drugs market, which includes medications used to treat a variety of bacterial, viral, and fungal infections. Oral antivirals are medications taken by mouth to treat viral infections, such as herpes, HIV, and influenza. These drugs work by interfering with the virus’s ability to replicate, thus preventing it from spreading and causing further damage. Oral antivirals are often used in combination with other treatments, such as topical creams or injections, to maximize their effectiveness. Oral antivirals are widely used in the treatment of many viral infections, and their use is increasing as new drugs are developed. They are generally well-tolerated and have fewer side effects than other treatments. However, they can be expensive and may not be available in all countries. Some companies in the Oral Antiviral market include Gilead Sciences, Merck, GlaxoSmithKline, and Bristol-Myers Squibb. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.